We investigated the association between undercarboxylated osteocalcin (ucOC) and lower-limb muscle strength in women over the age of 70 years. The study also aims to confirm the association between bone turnover markers and heel ultrasound measures. A post-hoc analysis using data collected as part of a randomized placebo-controlled trial of vitamin D supplementation. An immunoassay was used to quantify total OC (tOC), with hydroxyapatite pre-treatment for ucOC. We determined associations of absolute and relative (ucOC/tOC; ucOC%) measures of ucOC with lower-limb muscle strength, heel ultrasound measures of speed of sound (SOS) and broadband ultrasound attenuation (BUA), bone turnover markers (BTMs; P1NP and CTx) and the acute phase protein alpha-1-antichymotrypsin (-ACT). UcOC%, but not absolute ucOC concentration, was positively associated with hip flexor, hip abductor and quadriceps muscle strength (all p<0.05). ucOC% was negatively associated with -ACT (β-coefficient = -0.24, p=0.02). tOC was positively associated with both P1NP and CTx (p<0.001).
Introduction
Osteocalcin (OC) is an osteoblast-specific secreted protein. Its synthesis is exclusive to bone and serum levels reflect bone remodelling and, in particular, bone formation 1 . Recently novel metabolic roles of OC have been identified in preclinical studies, including increasing insulin secretion and sensitivity [2] [3] [4] . In humans, epidemiological studies demonstrate serum levels of total OC (tOC) are, in general, inversely associated with metabolic syndrome, measures of adiposity and glycaemia, and cardiovascular mortality 5 . The regulation of insulin sensitivity by OC may be either direct or indirect, via the adipocyte-derived hormone, adiponectin 1, 6 . In addition, increased bone fragility is common among adults with type 2 diabetes mellitus and may be related to changes in the material properties of bone.
Sarcopenia, a reduction in muscle mass, strength and function, is common in older adults and contributes to a reduction in the capacity to perform activities of daily living, and an increased risk of falls and fractures in the elderly 7, 8 . Sarcopenia has been associated with high levels of inflammatory markers, interleukin-6 and tumor necrosis alpha (TNF-), and with low levels of the acute phase reactive protein, alpha-1-antichymotrypsin (-ACT) 9 . Muscle strength is important for preventing and managing chronic metabolic, cardiovascular and musculoskeletal diseases, and is also associated with tOC 10 .
In bone and serum, OC is incompletely carboxylated (undercarboxylated OC) (ucOC) and it is the uncarboxylated form that has been linked to glucose homeostasis in mice. In the few human studies that have measured ucOC results have been equivocal 1 . Previously it was reported that exercise increases circulating levels of ucOC and that increases in ucOC correlated with the post-exercise reductions in serum glucose levels 11 . As skeletal muscle is a major site for glucose disposal 12, 13 it suggests the ucOC may have a link, directly or indirectly, to skeletal muscle function. In addition, there is some evidence to show that OC is related to muscle strength in
humans, but ucOC was not measured 10 . Preclinical studies also suggest ucOC induces mitochondrial proliferation and function in skeletal muscle 6 . Thus, data support a role for OC in the maintenance of muscle function in humans, although the relative importance of ucOC compared with tOC is unknown.
An association between ucOC and muscle strength would support a broader metabolic role for ucOC in humans. We investigated associations between absolute measures of tOC and ucOC, and a relative measure of ucOC (percent ucOC/tOC; ucOC%), with indices of muscle and bone health. The outcome parameters were lower-limb muscle strength measured at three sites; an acute phase protein associated with muscle strength (-ACT); serum bone turnover markers (N- 
Materials and Methods

Study design and population
A post-hoc analysis using data collected from a randomized placebo-controlled trial of vitamin D supplementation. Recruitment has been previously described 14 . Briefly the study was a single-centre, double-blind, randomized, placebo-controlled trial involving 2,317 communitydwelling women aged 70 years or older residing in southern Victoria, Australia (latitude 38°S).
Participants, defined as being at higher risk of hip fracture 14 identification study number, 150 participants of this study were randomly selected during recruitment and invited to participate in a sub-study that involved serial biochemistry and annual physical functioning assessments at the study centre. Of these, 137 consented to participate in the sub-study. These women had baseline lower limb muscle strength assessed and venepuncture prior to the first dose of study medication. These data have been analysed as a post-hoc analysis using observational study techniques.
Biochemical measurements
Blood samples were taken in the morning after a light breakfast. Samples were put on ice and were then centrifuged for three minutes at 3000g. Sera were stored in small aliquots, in the dark, The tOC intra-assay CV was <4.2% and the inter-assay CV <7.9. ucOC was measured using the same assay preceded by sample pre-treatment with a 100mg/ml hydroxyapatite slurry following the method described by Gundberg et al. 15 . The hydroxyapatite concentration has been established by a pilot study where we tested hydroxyapatite levels ranging from 4-100 mg/ml.
The final method had an intra-assay CV of <5.8% and inter-assay CV <7.9%. ucOC% was calculated as follows: ucOC/tOCx100.
Physical function assessments
Anthropometric
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Height and weight were measured with footwear removed using a wall-mounted tape measure for height (m) and digital scales (kg) for weight. Body mass index (BMI) was calculated as kg/m 2 .
Muscle strength
Peak eccentric muscle force at the hip flexors, hip abductors and quadriceps was measured using 
Statistical analyses
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Results
Of 137 sub-study participants, 90 had stored sera available for measurement of baseline osteocalcin and were therefore included in this analysis. The women had a median age of 75 years, a median BMI in the overweight range, mean serum tOC level of 18 ug/L and mean 25-hydroxyvitamin D level of 48 nmol/L (Table 1) .
There was a significant correlation between tOC and ucOC (r=0.52, p<0.001). ucOC% was associated with all three assessments of lower-limb muscle strength after adjusting for age ( Figure 1 and Table 2 ). The association for both quadriceps strength and hip abduction strength A C C E P T E D M A N U S C R I P T ucOC% was negatively associated with α-ACT (log α-ACT as the outcome, β-coefficient for ucOC% -0.244; p=0.021) and this association remained significant after adjustment for IL-6
concentrations. Neither tOC, nor ucOC, were associated with α-ACT (p=0.30 and p=0.18; tOC and ucOC, respectively). Serum 25(OH)D was not associated with tOC, ucOC or ucOC% (p value range: p=0.09 to 0.79), however PTH was associated with both tOC and ucOC, but not ucOC% (p=0.001, p=0.011 and p=0.42, respectively). None of the lower limb strength measures were associated with α-ACT (p value range: p=0.18 to 0.79).
As expected, tOC and ucOC were associated with both P1NP and CTx (p<0.02 for both).
Indices of bone quality from heel ultrasound were inversely associated with tOC after adjustment for age. Per unit increase in tOC (µg/L) there was a corresponding lower BUA, SOS and SI (β-co-efficient -0.28; -0.23 and -0.23, BUA, SOS and SI, respectively with corresponding p values of p=0.007; p=0.037 and p=0.032, respectively). tOC remained significantly associated
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9 with BUA after adjustment for age and BMI, however, all three indices were not significantly associated with any of the OC variables after further adjustment for PTH (p≥ 0.15). In addition, ucOC and ucOC% were not associated with any of the ultrasound measures in all three models (Table 2) . CTx was inversely associated with BAU (β-co-efficient -0.30, P=0.013) and positively with SOS (β-co-efficient 0.26, P=0.037). P1NP was not associated with any ultrasound measure (p>0.08).
Discussion
In this cohort of older Australian women, ucOC% was positively associated with lower-limb strength and negatively associated with -ACT. Importantly, since ucOC% was not associated with several indices of bone health the association is unlikely to be a proxy for skeletal metabolism and may support a role of ucOC in muscle function.
Total OC and other markers of bone turnover were not associated with lower-limb strength.
However, consistent with its known role as a marker of bone remodelling, the negative association of tOC with speed of sound (SOS), broadband ultrasound attenuation (BUA) and stiffness index (SI) suggests that higher rates of bone remodeling are associated with impaired bone material qualities. Both tOC and ucOC were positively associated with both bone turnover markers, P1NP and CTx. Higher bone remodelling in those with higher ucOC is consistent with data from Ferron et al. 3 suggesting ucOC is mainly released during osteoclastic resorption, where acidification in the lacunae causes decarboxylation of OC in the bone matrix. ucOC has a lower affinity for calcium and can more easily escape the bone. However both tOC and ucOC were positively associated with the bone formation marker P1NP and ucOC in human circulation could be the consequence of two separate processes: incomplete carboxylation, due to suboptimal vitamin K intake, or decarboxylation during osteoclast resorption 1 . In humans, the role of ucOC is intriguing and to date, it has not been clearly defined. Adults with poorer glycaemic control have lower ucOC% 11, 17, 18 , higher rates of bone turnover and consequently, increased bone fragility. Higher ucOC may be linked to increased risk of hip fracture through impaired -carboxylation and abnormal mineralisation and calcium binding 19 . On the other hand, lower ucOC% is negatively implicated in energy metabolism and glucose control in both mice and humans 2, 3 . Counterintuitively, although a lower ucOC% may be associated with better bone health, it may also be associated with impairments in glucose homeostasis. The interaction between ucOC, skeletal muscle and glycaemic control is currently unclear.
Anti-resorptive drugs used to treat osteoporosis do not have negative effects on insulin sensitivity or lead to higher circulating levels of glucose 20 , although these drugs are known to reduce circulating levels of tOC and ucOC (by 30-50%) 21, 22 . Glucocorticoid therapy reduces tOC and ucOC production by more than 80% 23 and can lead to insulin resistance and type 2 diabetes and muscle atrophy 24 . The findings of the current study extends that of Fernandez-Real et al. 10 who first demonstrated that tOC is related to muscle strength in humans, but no measurements of ucOC were made. Although our study did not find an association with tOC, it clearly demonstrates that ucOC% is associated with muscle strength in this group of older women. Fernandez-Real and colleagues proposed that OC represents the missing link in exercise-induced improvement in insulin sensitivity 10 . We subsequently demonstrated that the exercise-induced increase in ucOC is associated with post-exercise reduction in serum glucose levels 11 . Exercise is recommended as the primary strategy for preventing and reversing agerelated sarcopenia 25 . The results from the present study suggest that exercise programs aimed at improving muscle strength (such as resistance training) in older adults may also have a positive effect on ucOC%.
We found a negative correlation between ucOC% and -ACT, an acute-phase reactive protein that has been associated with the inflammatory mechanisms of sarcopenia 9 , which were not
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11 related with changes in serum levels of IL-6. The inverse association between ucOC% and -ACT indicates that it is likely those with more "active" lifestyle, as measured by increased muscle strength, will have lower levels of -ACT and higher ucOC. However, increased circulating levels of cytokines are implicated in the development and the progression of many chronic diseases, including osteoporosis. The role, and the effect, of -ACT in muscle function and the development of chronic diseases is intriguing and not fully understood. Some studies reported that -ACT may be expressed during muscle injury and involved in the development of diseases such as Alzheimer disease 26, 27 . Other studies however have reported that -ACT is expressed during myogenesis and that high levels of -ACT may decrease the rate of age-related loss of muscle mass and strength in older men and women 9 . Nevertheless, in the current cohort no association between -ACT and absolute muscle strength was observed. Possible interactions between higher ucOC, increased muscle strength and -ACT levels combining to improve glycaemic control warrant further investigation in prospective exercise intervention studies.
The limitations of the study include the relatively small sample size (n=90) and the crosssectional study design means causality cannot be determined. We did not assess vitamin K intake or measure serum vitamin K levels, which may affect the carboxylation of OC. However, we have no reason to suspect that vitamin K intake was suboptimal in this group of women as the normal level of ucOC% in human serum is ≤ 50% 1 and in the current group the median ucOC% was 24.9% (Table 1) . Although some serum bone turnover marker levels, including OC, may be affected by impaired renal function, women with known renal disorders and/or serum creatinine levels greater than 150 umol/L were excluded from the study 14 .
In conclusion, ucOC% was associated with increased lower-limb strength and negatively correlated with -ACT in older women. The association may support a metabolic role for ucOC in muscle function. The results also confirm tOC is associated with other indices of bone health and provide a potential link whereby tOC, ucOC% and ucOC are each related to musculoskeletal health and also combine to influence the risk of falls and fracture in the elderly. Table 1 . 
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